Skip to main content
. Author manuscript; available in PMC: 2025 May 1.
Published in final edited form as: Exp Eye Res. 2024 Mar 8;242:109852. doi: 10.1016/j.exer.2024.109852

Table 2.

Levels (pmol/mg of protein) of specific ceramide, monohexosylceramide, sphingomyelin and ceramide-1-phosphate species among the different groups in 661W cells.

Ceramide (pmol/mg) Control L-Cs only H2O2 only L-Cs + H2O2
C14:0 0.63 ± 0.09 0.81 ± 0.14 0.57 ± 0.11 0.59 ± 0.14
C16:0 25.36 ± 2.77 25.50 ± 4.25 31.05 ± 9.33 21.51 ± 3.15
C16 DH 1.67 ± 0.19 1.66 ± 0.18 15.25 ± 4.31b 4.93 ± 0.65 f
C18:1 13.67 ± 4.08 16.00 ± 3.67 25.21 ± 8.75 19.54 ± 4.82
C18:0 4.76 ± 1.05 4.67 ± 0.8 5.40 ± 1.79 4.89 ± 0.7
C20:0 4.31 ± 0.38 3.68 ± 0.43 4.56 ± 1.52 2.66 ± 0.23
C22:0 27.10 ± 2.15 26.49 ± 2.10 22.27 ± 6.9 14.42 ± 1.32
C24:1 53.50 ± 5.01 47.69 ± 4.78 39.12 ± 9.81 31.22 ± 3.73
C24:0 56.43 ± 6.13 51.59 ± 5.64 29.35 ± 8.14 c 21.54 ± 2.51
C26:1 21.60 ± 2.5 18.00 ± 2.22 10.60 ± 3.09 b 8.01 ± 0.65
C26:0 0.93 ± 0.12 0.70 ± 0.15 0.48 ± 0.11 c 0.26 ± 0.02 f
Monohexosylceramide (pmol/mg) Control L-Cs only H2O2 only L-Cs + H 2 O 2
C14:0 1.20 ± 0.15 1.73 ± 0.21 1.15 ± 0.15 1.05 ± 0.21
C16:0 216.71 ± 44.32 228.93 ± 31.8 125.61 ± 44.32 101.75 ± 31.8
C16 DH 2.45 ± 1.38 0.42 ± 0.09 0.72 ± 1.38 0.57 ± 0.09
C18:1 32.53 ± 9.07 39.00 ± 5.92 25.98 ± 9.07 21.06 ± 5.92
C18:0 19.58 ± 3.02 23.85 ± 3.8 16.81 ± 3.02 13.06 ± 3.8 f
C20:0 11.52 ± 1.36 12.98 ± 1.55 11.68 ± 1.36 8.04 ± 1.55 f
C22:0 119.15 ± 5.94 130.37 ± 13.14 107.95 ± 5.94 65.36 ± 13.14 e
C24:1 133.63 ± 7.84 146.68 ± 14.74 121.48 ± 7.84 90.82 ± 14.74
C24:0 272.46 ± 17.6 359.24 ± 34.20 245.00 ± 17.6 179.88 ± 34.2 f
C26:1 22.06 ± 1.72 23.80 ± 2.18 19.78 ± 1.72 14.79 ± 2.18 f
C26:0 3.60 ± 0.26 3.57 ± 0.33 2.74 ± 0.26 1.76 ± 0.33 f
Sphingomyelin (pmol/mg) Control L-Cs only H2O2 only L-Cs + H 2 O 2
C14:0 29.53 ± 2.49 24.63 ± 1.88 13.24 ± 2.01 a 12.85 ± 0.79
C16:0 275.04 ± 34.24 298.71 ± 27.41 188.19 ± 148.51 180.11 ± 26.18
C16 DH 24.75 ± 4.55 24.18 ± 4.20 27.90 ± 23.81 24.88 ± 3.92
C18:1 6.82 ± 1.71 7.074 ± 1.4 2.68 ± 3.27 3.07 ± 0.83
C18:0 59.06 ± 7.60 49.77 ± 8.18 34.09 ± 24.68 27.29 ± 4.51
C20:0 17.13 ± 0.99 15.23 ± 1.12 9.36 ± 5.7 9.19 ± 0.5
C22:0 67.63 ± 3.88 61.08 ± 4.96 36.41 ± 23.49 31.59 ± 2.31
C24:1 178.86 ± 11.73 170.84 ± 8.93 107.17 ± 64.13 95.65 ± 5.53
C24:0 90.12 ± 7.77 87.99 ± 6.42 48.73 ± 33.27 40.87 ± 3.23
C26:1 2.77 ± 0.3 2.83 ± 0.19 1.56 ± 0.95 1.30 ± 0.09
C26:0 0.81 ± 0.09 0.79 ± 0.07 0.43 ± 0.25 0.35 ± 0.03
Ceramide-1-phosphate (pmol/mg) Control L-Cs only H2O2 only L-Cs + H2O2
C14:0 4.50 ± 0.35 4.22 ± 0.26 4.52 ± 0.97 c 4.76 ± 0.24
C16:0 0.50 ± 0.12 0.33 ± 0.07 0.68 ± 0.59 0.46 ± 0.08

Footnote: Semiquantitative levels (pmol/mg of protein) of specific ceramide, monohexosylceramide, sphingomyelin and ceramide-1-phosphate species among the different groups in 661W cells (n = 6/group). Control: cells having no treatment with L-Cs or H2O2; L-Cs only: treated with 10 μM L-Cs for 3 h; H2O2 only: treated with 300 μM of H2O2 for 3 h; L-Cs + H2O2: cotreated with 10 μM L-Cs and 300 μM H2O2 for 3 h. Values are represented as mean ± SEM; t-test;

a

P < 0.001 between H2O2 only treated group and control;

b

P < 0.01 between H2O2 only treated group and control;

c

P < 0.05 between H2O2 only treated group and control;

e

P < 0.01 between L-Cs + H2O2 treated group and H2O2 only treated group;

f

P < 0.05 between L-Cs + H2O2 treated group and H2O2 only treated group;